Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of obesity phenotypes with incident fall rates: results from the objective physical activity and cardiovascular disease health in older women study.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.

NPJ breast cancer·2026
Same author

Sleep pattern clusters, physical function and fall risk: geriatric syndromes among older ambulatory women.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

Biological Sex Differences in the US-CTEPH-R.

Annals of the American Thoracic Society·2026
Same author

Association of epigenetic age acceleration with MRI biomarkers of aging and Alzheimer's disease neurodegeneration.

Aging·2026
Same author

Plasma Phosphorylated Tau 217 and Incident Mild Cognitive Impairment and Dementia in Older Women.

JAMA network open·2026

Related Experiment Video

Updated: Jun 23, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology
03:59

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Provider attributes associated with hormone therapy prescribing frequency.

Leslie Spangler1, Susan D Reed, Larissa Nekhyludov

  • 1Group Health Center for Health Studies, University of Washington Seattle, WA 98101, USA. spangler.l@ghc.org

Menopause (New York, N.Y.)
|May 2, 2009
PubMed
Summary

Provider characteristics like confidence and practice location influence hormone therapy prescribing. Factors differ between primary care providers and obstetrician/gynecologists, impacting treatment decisions for women.

Related Experiment Videos

Last Updated: Jun 23, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology
03:59

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Area of Science:

  • Reproductive Medicine
  • Clinical Practice Guidelines
  • Healthcare Provider Behavior

Background:

  • Hormone therapy (HT) prescribing patterns changed significantly following the Women's Health Initiative (WHI) study.
  • Understanding factors influencing HT prescribing is crucial for evidence-based patient care.

Purpose of the Study:

  • To identify provider characteristics associated with hormone therapy prescribing.
  • To explore differences in prescribing correlates between primary care providers and obstetrician/gynecologists.

Main Methods:

  • Cross-sectional survey study of providers in two integrated healthcare systems.
  • Data collected on provider demographics, practice characteristics, and perceptions of hormone therapy.
  • Hormone therapy prescribing frequency calculated and analyzed using bivariate and multivariate methods.

Main Results:

  • Hormone therapy prescribing varied by practice site and provider tenure in both primary care and OB/GYN groups.
  • For primary care providers, expert knowledge of HT trials correlated with higher prescribing.
  • For OB/GYNs, confidence in counseling, belief in exaggerated risks, and seeing younger patients were associated with higher prescribing.

Conclusions:

  • Provider confidence, practice location, and organizational tenure are key factors in hormone therapy prescribing.
  • Specific provider beliefs and patient demographics influence prescribing decisions differently across specialties.
  • Clinical guidelines and study findings impact provider behavior, but individual characteristics remain significant predictors.